Verona Pharma (VRNA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist

27.490
+0.240+0.88%

Close Aug 16 16:00 ET

27.400
-0.090-0.33%

Post 19:29 ET

2.23BMarket Cap-17181P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
MT NewswiresAug 16 11:16 ET
Don't Ignore The Insider Selling In Verona Pharma
Simply Wall StAug 16 06:14 ET
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
MT NewswiresAug 15 11:19 ET
Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)
InvestingAug 14 18:02 ET
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading
MT NewswiresAug 14 11:08 ET
CCORF Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $37
Moomoo NewsAug 14 07:31 ET · Ratings

Comments

Xyno

Aug 15 05:14

$Verona Pharma (VRNA.US)$ Wow, the recent earnings - which was not really earnings yet - gave this a greay boost. pre-market i am officially 100% up !

Xyno

Jul 31 07:11

$Verona Pharma (VRNA.US)$ earnings on 8/8 and hopefully new announcements!

Xyno

Jul 10 18:38

$Verona Pharma (VRNA.US)$ and finally it seems all brakes are loose and it is going to the top!

Xyno

Jun 27 07:23

$Verona Pharma (VRNA.US)$ Price pressure has begun in pre-market, which looks unreal for a company receicing approval for a novel - and potentially groundbreaking - drug.
Stay calm, dont play in the hands of the shorts. Make sure your stock cannot be borrowed for shorts as well.

Xyno

Jun 27 03:27

Be cautious

$Verona Pharma (VRNA.US)$ shorters will try to push it down. this is a long term hold being a blockbuster drug, with a 2 billion potential further down the road. revenue forecast for this year 40 million. hopefully conference call is giving the price a boost. if a big pharma might do a take over, it goes sky rocketing. whatever it is, don’t sell cheap. Disclaimer: not financial advice.

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

VRNA Verona Pharma

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target